Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

David Granath appointed CFO of Careium from 22 August 2024

Careium, the European champion in technology enabled care, has appointed David Granath CFO effective 22 August 2024. David comes most recently from the CFO role at an energy storage company Polarium and was previously CFO at an e-commerce group Qliro Group, both publicly listed companies. He brings international experience from a long career in finance across its multiple sub-disciplines as he started his career at Applied Value, a management consultancy based in the US. David holds a Master’s degree in industrial management and engineering from Linköping University. “I’m thrilled to

Invitation to presentation in connection with EQL Pharma's interim report, first quarter, 2024/25

EQL Pharma AB (publ) will publish its interim report for the first quarter, 2024/25, on Thursday, August 8[th], before stock markets opening.At 10.00 (CET) 8[th] August, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the interim report. After the presentation, there is an opportunity to ask questions for those who participate. Use the following link to access the virtual meeting: https://tinyurl.com/pftxx2ys Date and time August 8[th], 2024, at

Danieli chosen as technology provider for fossil-free steel mini-mill in Luleå, Sweden

SSAB and Danieli have signed an Early Service Agreement (ESA) on the pre- and engineering phase for the Luleå mini-mill project in Sweden. Under the agreement, Danieli will supply a highly-automated technology solution for the new mini-mill, consisting of two electric arc furnaces, secondary metallurgy, caster and strip mill. Participants from SSAB and Danieli kick off the project at Danieli’s plant in Buttrio, Italy. In April this year, SSAB’s Board of Directors took the decision to build a state-of-the-art fossil-free mini-mill in Luleå as the next step in SSAB’s transformation

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 159 – 15 JULY 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 158 – 15 JULY 2024   On 25 April 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 26 April 2024 up to and including no later than 1 August 2024. For details, please see announcement no. 96 of 25 April 2024.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 21 million (approximately DKK 145 million).

TORM purchases eight and sells one second-hand MR vessel, increasing the fleet size to 96 vessels

On 15 July 2024, TORM has entered into an agreement to acquire eight second-hand MR vessels that are expected to be delivered during Q3 2024 and Q4 2024 for a total consideration of USD 340m, with a cash consideration of USD 238m and the issuance of approximately 2.65 million shares. The purchase price is subject to certain adjustments that will be impacted by TORM’s share price development and the vessels’ delivery schedules.   The vessels have all been built at the Tier 1-Korean yard Hyundai Mipo Dockyard in 2014-2015, and six of the vessels have been fitted with scrubbers. The cash

Cyxone provides an update on its research and development program

Cyxone (publ) is a biotech company with two promising clinical stage drug candidates, rabeximod and T20K, for autoimmune diseases. The company announces an updated development plan that aligns with the revised strategy revealed in August 2023, aiming to bring hope to patients suffering from these conditions.In April of this year, Kjell Stenberg, a seasoned leader in the biotech industry, was appointed as the company's new CEO. In collaboration with an external team of key opinion leaders and an internal team, Dr. Stenberg reviewed the latest findings for both the rabeximod and T20K projects.

Extended Strategic Partnership between 24SevenOffice and HSB, Sweden’s largest federation of cooperative housing

HSB has signed a strategic and extended agreement with 24SevenOffice for an additional 4.5 years. The expected annual turnover for the agreement is approximately SEK 10 million. As the largest federation of cooperative housing in Sweden, HSB has been innovatively organizing cooperatives for over 100 years with the aim of improving housing and increasing residents' influence over their housing situation.  HSB manages invoice processing for more than 4,000 housing associations and approximately 350,000 apartments and 677,000 members. The AI accounting collaboration, which has been going on

Flowscape wins contract with Swedish authority

A Swedish government agency, with very high security requirements, chooses Flowscape as a supplier for smart office solutions for its offices in Sweden.  The order value for the first phase of the project amounts to 1100,000 SEK (97,500 EURO) and thereafter 195,000 SEK (17,500 EURO) annually"We are once again proving that our solutions can handle the highest safety requirements while the solution is the most modern in terms of functionality. This client wanted to be able to combine a tool for their hybrid way of working with workspace and room bookings, while at the same time being able to

Ericsson and OPPO sign global patent cross license agreement

· Multi-year global cross license covering cellular technology, including 5G · Royalty payments from OPPO to Ericsson · Business cooperation on 5G related projects such as device testing and customer engagementsEricsson (NASDAQ:ERIC) and OPPO have signed a multi-year global patent cross license agreement. This agreement includes a cross license covering patents essential to standards for cellular technologies, including 5G. OPPO, a leading smartphone vendor with sales in global markets, and significant presence in developing countries, will make royalty payments to Ericsson. In

Acquisition of Amolyt Pharma completed

15 July 2024 Acquisition of Amolyt Pharma completed AstraZeneca today announced the successful completion of theacquisition  of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. The acquisition bolsters the Alexion, AstraZeneca Rare Disease late-stage pipeline and expands on its bone metabolism franchise with the notable addition of eneboparatide (AZP-3601), a Phase III investigational therapeutic peptide with a

Handelsbanken’s interim report for January – June 2024 will be presented Wednesday 17 July

Handelsbanken publishes its interim report for January ­– June 2024, at 07:00 a.m. CET Wednesday, 17 July. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. Chief Executive Officer, Michael Green, will present the interim report at 09:00 a.m. CET. The presentation will be broadcasted live and available at handelsbanken.com/ir. The presentation will be followed by a short break, after which a Q&A session will follow for analysts, investors and media with Michael Green, Carl Cederschiöld, CFO, and Peter Grabe, Head of Investor Relations. Telephone

Esmaeilzadeh Holding publishes net asset value as of 30 June 2024

As of 30 June 2024, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 6.64 billion (SEK 7.10 billion as of 31 May 2024), corresponding to a net asset value per share of SEK 8,460 (SEK 9,062 as of 31 May 2024).[1]  For further information, please contact: Mikael Ericson, CEO mikael.ericson@ehab.group For press related enquires, please contact: Michaela Abercrombie Simpson, Head of Communication Phone: +46 736 301 403 The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 15 July 2024. About

Flexion signs Top Grossing game Zombie Waves

LONDON, 15 July 2024 – Flexion (Nasdaq: FLEXM), the games marketing company has signed an agreement with Fun Formula, a global developer and publisher of cutting-edge casual games, to publish the developer’s successful game Zombie Waves on the alternative app stores. Flexion will distribute the game on the following platforms: Amazon Appstore, Huawei AppGallery, Samsung Galaxy Store, Xiaomi GetApps, DT Hub and ONE store. Zombie Waves is expected to launch on these platforms in September 2024. Flexion is adding an average of 10% to a game’s Google Play revenue by taking it to the

PixelFox Reports Preliminary Revenue and Operating profit for June 2024

Stockholm, July 15, 2024  Period Turnover Operating Result 2024 Turnover 2023 Operating Result 2023 2024June 2,9 MSEK 0,1 MSEK 3,6 MSEK 0,1 MSEK PixelFox has managed to maintain a positive result despite a slight decrease in revenue. The group's efforts and strategies have been crucial in ensuring continued profitability while focusing on developing our core business.For further information, please contact:Robin BäcklundChief Executive OfficerPixelFox AB (publ)ir@wearepixelfox.comPixelFox AB (publ)The business idea of PixelFox AB (

Skanska expands hospital in Astoria, Oregon, USA for USD 74M, about SEK 780M

Skanska has signed a contract with Columbia Memorial Hospital for a hospital expansion project in Astoria, Oregon, USA. The contract is worth USD 74M, about SEK 780M, which will be included in the US order bookings for the third quarter of 2024.The project includes a four story 16,900 square meter (182,000-SF) expansion to the existing hospital to include an expanded emergency department, improved operating rooms, larger patient rooms, space for mechanical equipment, among other enhancements. The expansion will allow Columbia Memorial Hospital to provide new services and the latest medical

Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

OSLO, NORWAY - July 15, 2024: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which was announced in a press release on the 01.07.2024 has now been registered with the Norwegian Register of Business Enterprises (No. Foretaksregisteret).GA announced that a direct issue was completed on the 01.07.2024 This provided the Company with approximately NOK 4.97 million by issuance of 6 625 916 new shares, before issue costs. The direct issue has now been registered with the Norwegian Register of Business Enterprises. After this, the Company'

Knox Energy Solutions AS - Annual general meeting completed and notice of reverse share split

(Oslo, 15 July 2024) Knox Energy Solutions AS (Knox, OSE: KNOX) announces that its annual general meeting was held Friday, 12 July 2024, as a virtual meeting, with no physical attendance. The decision was made to do a reverse share split of 100:1 of the shares.All items on the agenda were adopted in accordance with the proposals of the board of directors of Knox. The minutes from the Annual General Meeting will be made available on the company’s website. The decision was made by the required majority to do a reverse share split. The reverse share split was decided as follows: · 100

Bonava is selling project of 89 rental apartments in Germany

Bonava is selling a package of 89 rental apartments in Düsseldorf, Germany, to the investor WOHNBAU GmbH from Bonn. The housing units are expected to be completed and handed over to the customer in the fourth quarter of 2026. Production will start in the third quarter of 2024.– There is huge demand for sustainable rental apartments in Düsseldorf, and it is gratifying that we, despite the current market conditions, can both sell and start this project. There is widespread interest in our rental housing projects, and in the investor segment buyers and sellers are once again starting to do

Interim Report 1 January – 30 June 2024

Good growth in both Business Areas and continued profitability improvement "The companies within AddLife showed strong performance development during the quarter. In Labtech, sales growth recovered as expected and margins remained stable. Sales growth in Medtech was good and margins improved partly driven by restructuring efforts that are now yielding clear results. Cash flow improved significantly and after the end of the quarter, an acquisition was made in line with our updated long-term strategy."Fredrik Dalborg, President and CEO AddLife´s interim report for Q2 2024 is now

Ellos Group withdraws proposal to issue new bonds and to redeem its outstanding super senior bonds prior to maturity – discussion with bondholders continues

NOT FOR DISTRIBUTION IN OR TO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO PUBLISH OR DISTRIBUTE THIS PRESS RELEASEPress release, Borås, 15 July 2024  On 11 June 2024, Ellos Group AB (publ) (“Ellos Group” or the “Company”) announced that its subsidiary Ellos Group Nordic AB (publ) contemplated an issuance of new senior secured bonds and super senior secured bonds (the “New Bonds Issue”) for the purpose of, inter alia,

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

· Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) · Increased biochemical response rates (IGF-1≤1xULN) vs SoC at baseline · Continuous improvement of acromegaly symptom and quality of life scores vs baseline · Study results reinforce previously reported interim results from ACROINNOVA 2[1] Lund, Sweden, 15 July 2024 — Camurus (NASDAQ STO: CAMX) today announced positive, final, topline results from the 52-week Phase 3 open-label ACROINNOVA 2 (NCT04125836) study, which evaluated safety and efficacy of the company’s once-monthly octreotide

There are no items matching the current filter
There are no more items matching the current filter
Back to top